Shares of Moderna rose by a staggering 10.78% to $109.18 yesterday on Thursday, following the previous day downward trend. The Nasdaq Stock Market rose 0.48% to $12,094.40.
According to Tuedays’s article on Bloomberg Quint, “Moderna Soars to Record Ahead of Final Covid Vaccine Analysis.”
Moderna’s last close was $98.56, 0.48% under its 52-week high of $108.66.
Moderna’s sales growth is 1271.1% for the present quarter and 5174.8% for the next. The company’s growth estimates for the current quarter is a negative 62.2% and positive 254.3% for the next.
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s stock is valued at $109.18 at 08:28 EST, higher than its 52-week high of $108.66.
Moderna’s worth is way above its 50-day moving average of $77.77 and way above its 200-day moving average of $70.18.
According to Bloomberg Quint on Mon Nov 23, “Moderna Chief Sells More Shares Ahead of Urgent Vaccine Filing.”